HUM:NYSE (USA) Also trade in: Germany

Humana Inc

$ 240.69 7.8 (3.35%)
On watch
Volume: 2,018,738 Avg Vol (1m): 1,415,604
Market Cap $: 32.65 Bil Enterprise Value $: 26.52 Bil
P/E (TTM): 19.81 P/B: 3.21
Earnings Power Value 2.48
Net Current Asset Value 0
Tangible Book 44.4
Projected FCF 177.62
Median P/S Value 164.48
Graham Number 110.17
Peter Lynch Value 109.59
DCF (FCF Based) 122.12
DCF (Earnings Based) 156.47
YTD (-%)

Financial Strength : 5/10

Current vs industry vs history
Cash-to-Debt 0.38
Equity-to-Asset 0.40
Debt-to-Equity 0.61
Debt-to-EBITDA 2.22
Beneish M-Score -2.45
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC 423.83%
WACC 8.27%

Profitability & Growth : 5/10

Current vs industry vs history
Net Margin % 2.96
ROE % 16.54
ROA % 5.69
3-Year Total Revenue Growth Rate 1.60
3-Year Total EBITDA Growth Rate -2.80
3-Year EPS w/o NRI Growth Rate 12.90

» HUM's 30-Y Financials

Financials (Next Earnings Date: 2019-05-01)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NYSE:HUM

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Health Care Plans » Health Care Plans    NAICS : 621610    SIC : 6324
Compare NYSE:CI NAS:ESRX NYSE:AET NYSE:ANTM NYSE:CNC NYSE:CVS NYSE:WCG NYSE:MOH BSP:ODPV3 BSP:QUAL3 NAS:MGLN XPAR:GDS NAS:HIIQ OSTO:MCOV B ROCO:6665 ATH:IATR ASX:ONT TSXV:NAC MIL:HI OTCPK:HFRN
Traded in other countries
Address 500 West Main Street, Louisville, KY, USA, 40202
Humana Inc is one of the largest and best-known providers of Medicare Advantage plans in the U.S. The firm specializes in providing government-sponsored plans, with close to three fourths of its membership tied to Medicare, Medicaid, or some other form of government healthcare program. Humana is also building an extensive provider network in key geographic areas in order to control the use and cost of healthcare services to its membership. These network and the firm's brand name will also make it a major player in the nascent public exchange market.

Ratios

Current vs industry vs history
PE Ratio (TTM) 19.81
Forward PE Ratio 13.91
N/A
PE Ratio without NRI 19.81
Price-to-Owner-Earnings 47.31
PB Ratio 3.21
PS Ratio 0.59
Price-to-Free-Cash-Flow 21.50
Price-to-Operating-Cash-Flow 15.41
EV-to-EBIT 11.63
EV-to-EBITDA 9.42
EV-to-Revenue 0.47
PEG Ratio 2.41
Shiller PE Ratio 26.58

Dividend & Buy Back

Current vs industry vs history
Dividend Yield % 0.83
Dividend Payout Ratio 0.16
3-Year Dividend Growth Rate (Per Share) 20.30
Forward Dividend Yield % 0.83
N/A
Yield-on-Cost (5-Year) % 1.56
3-Year Share Buyback Rate 2.90

Valuation & Return

Current vs industry vs history
Price-to-Tangible-Book 5.42
Price-to-Projected-FCF 1.35
Price-to-DCF (Earnings Based) 1.54
Price-to-Median-PS-Value 1.46
Price-to-Peter-Lynch-Fair-Value 2.19
Price-to-Graham-Number 2.18
Earnings Yield (Joel Greenblatt) % 8.60
Forward Rate of Return (Yacktman) % 13.14

More Statistics

Revenue (TTM) (Mil) $ 56,912
EPS (TTM) $ 12.15
Beta 1.11
Volatility % 24.18
52-Week Range $ 225.65 - 355.88
Shares Outstanding (Mil) 135.64

Analyst Estimate

Piotroski F-Score Details